Research programme: adenosine A2A receptor agonist stress agents - Adenosine Therapeutics

Drug Profile

Research programme: adenosine A2A receptor agonist stress agents - Adenosine Therapeutics

Alternative Names: ATL 193; JMR 193

Latest Information Update: 07 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Virginia
  • Class Diagnostic agents
  • Mechanism of Action Adenosine A2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cardiomyopathies

Most Recent Events

  • 13 Sep 2005 This compound is still in active development
  • 11 May 2000 Preclinical development for Cardiomyopathy (diagnosis) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top